drugset / Trial / NCT01082120
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine whether administration of AZD1656 will affect the pharmacokinetics of Pioglitazone and vice versa in patients with Type 2 Diabetes Mellitus.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1656 | Small molecule | — | Oral |
| Subject | Pioglitazone | Small molecule | — | Oral |